Related Experiment Video
Updated: Jun 20, 2026
05:48
The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
[Update on attention-deficit/hyperactive disorder treatment]
M Loro-López1, J Quintero, N García-Campos
1Instituto Neuroconductual, Hospital Infanta Leonor, Madrid, España.
Revista De Neurologia
|August 29, 2009
Summary
Attention-deficit/hyperactive disorder (ADHD) requires tailored treatment plans. Combining psychostimulants and psychological approaches offers effective ADHD management, considering patient and family preferences.
Area of Science:
- Neuropsychiatry
- Pediatric Medicine
- Pharmacology
Context:
- Attention-deficit/hyperactive disorder (ADHD) is a prevalent childhood neuropsychiatric condition significantly impacting daily life.
- Effective ADHD management necessitates a comprehensive treatment strategy addressing the chronic nature of the disorder.
- Patient and family involvement is crucial in developing individualized ADHD treatment plans.
Purpose:
- To provide an updated overview of psychopharmacological and psychological treatments for ADHD.
- To evaluate the efficacy of single-drug versus combined treatment approaches for ADHD.
- To highlight the importance of personalized treatment strategies in ADHD management.
Summary:
- Psychostimulants are the established gold-standard treatment for ADHD, demonstrating high response rates (65-85%).
- Atomoxetine presents a viable alternative pharmacotherapy for ADHD, with approvals from major regulatory agencies.
- Comprehensive ADHD treatment integrates psychoeducation, current medical evidence, and patient/family preferences.
Impact:
- Optimized ADHD treatment plans enhance patient quality of life.
- Understanding treatment efficacy guides clinical decision-making for ADHD.
- Addressing comorbidities is essential for improving outcomes in non-responder ADHD patients.
More Related Videos
10:02Event Related Potentials (ERPs) and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder (ADHD)
Published on: March 12, 2020
13:09Using Brain Activation (nir-HEG/Q-EEG) and Execution Measures (CPTs) in a ADHD Assessment Protocol
Published on: April 1, 2018
Related Concept Videos
01:30Attention-Deficit/Hyperactivity Disorder
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its effects by...
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...